Industry Keen On ‘Stepwise’ PIPs, But Future Hinges On EU Pharma Legislation Reform

 
• By Eliza Slawther
  
Industry is eager to implement a new stepwise approach to pediatric investigation plans in the EU (Shutterstock)

More from Approval Standards

More from Pathways & Standards